Nervive, Inc. Company
Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury. Founded in 2013, Nervive is headquartered in Akron, Ohio.
Founded Date:
2013-12-31
Last Funding Type:
Grant
Headquarters:
Akron, Ohio, United States
Investors Number:
3
Technology:
NeuroTech
Employee Number:
1-10
Industry:
Health Care, Medical, Wellness
Estimated Revenue:
Less than $1M
Total Funding:
$3.6M